Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity
- 1 October 1992
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (4) , 1191-1196
- https://doi.org/10.1016/s0002-9378(12)90410-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolitesAmerican Journal of Obstetrics and Gynecology, 1990
- Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulinSteroids, 1990
- Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestinsContraception, 1990
- The Selectivity of a New ProgestinActa Obstetricia et Gynecologica Scandinavica, 1990
- Metabolic effects of oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1987
- A comparison of the potencies and activities of progestogens used in contraceptivesContraception, 1987
- The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterusContraception, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1982